Not Disclosed
a part of CareTech Group
has agreed to be acquired by
Pending
Healthcare IT
Jessica Litwin
Director, Medical Technology
About Jessica
Jessica Litwin is a director for William Blair based in the firm’s Chicago office. She joined the investment banking team in 2020. Before William Blair, she worked for Allier Capital, Commonwealth Bank of Australia, and Australia and New Zealand Banking Group (ANZ).
Board Membership
Chicago Sinfonietta (since 2023), chair of the Nominations and Governance Committee
Notable Transactions
Not Disclosed
a portfolio company of
DW Healthcare Partners
has been acquired by
January 2026
Medical Technology
Not Disclosed
Senior Secured Term Loan (Add-on)
June 2025
Medical Technology
$57,500,000
Follow-on Offering
February 2025
Medical Technology
Not Disclosed
Senior Secured Term Loan
February 2025
Medical Technology
$207,348,473
Initial Public Offering
October 2024
Medical Technology
Last week, William Blair acted as an underwriter on three healthcare IPOs: Upstream Bio’s (NASDAQ:UPB) $293 million IPO, CAMP4 Therapeutics’ (NASDAQ: CAMP) $75 million IPO, and Ceribell’s (NASDAQ: CBLL) $207 million IPO.
Read more
$12,000,000
Registered Direct
August 2023
Medical Technology
$37,375,000
Follow-on Offering
February 2023
Medical Technology
Not Disclosed
a portfolio company of
Roundtable Healthcare Partners
has been acquired by
a portfolio company of Audax Group
October 2022
Medical Technology
William Blair acted as lead financial advisor to Symmetry Surgical, a portfolio company of RoundTable Healthcare Partners, in connection with its sale to Aspen Surgical Products, a portfolio company of Audax Group.
Read more
Not Disclosed
has been acquired by
December 2021
Medical Technology
William Blair acted as exclusive financial advisor to Norwood Medical in connection with its sale to Heraeus.
Read more
$125,000,000
has been acquired by
October 2021
Medical Technology
Not Disclosed
has been acquired by
September 2021
Medical Technology
William Blair acted as exclusive financial advisor to GCX Corp. in connection with its sale to Audax Group.
Read moreRigorous pursuit of your success. Every transaction. Every time.
Our investment bankers are 100 percent committed to your organization’s sustained success. By drawing on our deep industry and product experience as well as our dedicated global resources, we provide advisory and financing services that allow you to capitalize on today’s opportunities and anticipate tomorrow’s challenges.
More about investment banking at William Blair
Medical Technology
William Blair’s Medical Technology team works with many of the world’s most innovative medical technology companies to help transform their growth trajectory through capital access and M&A partnerships. By combining deep expertise in the mega trends driving life science and medical product innovation and our knowledge of the regulatory and reimbursement environment, we deliver trusted advice and outstanding execution for market-leading companies and financial sponsors.
Learn more about our medical technology expertise
About William Blair
William Blair is a premier global partnership with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 30 offices worldwide.*
-
1935Year William Blair was founded
-
1,950+Employees worldwide
-
154 billion+Client assets
-
90+ YearsIndependent and employee-owned
-
30+Offices worldwide*
-
650+Companies under coverage
As of December 31, 2025
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Equity.